Skip to main content
Premium Trial:

Request an Annual Quote

Tripos to Sell Informatics Business to Vector Capital for $25.6M as First Step in Liquidation

NEW YORK (GenomeWeb News) - Tripos today said it has agreed to sell its Discovery Informatics business to San Francisco-based Vector Capital for $26.5 million in cash as an “initial step” in the liquidation of the company.
 
The transaction is expected to close in the first quarter of 2007.
 
Vector Capital is a boutique private equity firm that specializes in technology recapitalization deals, buyouts, and spin-outs.
 
Tripos disclosed its plans to sell its Discovery Informatics and Discovery Research businesses last week.
 
Tripos said that it expects to distribute between $6 million to $12 million to its shareholders assuming completion of the sale of its Discovery Informatics business to Vector, sale of its Discovery Research business, and completion of certain other transactions.
 
The sale of the Discovery Informatics assets to Vector will allow the business “to continue to serve its computational chemistry and enterprise research IT customers as a private company with greater access to growth capital," said John McAlister, president and CEO of Tripos, in a statement.

Filed under

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.